Marshall Wace
BHST

Marshall Wace’s BioHarvest Sciences BHST Stock Holding History

Marshall Wace’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,235
Closed -$110K – 3773
2025
Q4 		$110K Buy
+21,235
New +$170K ﹤0.01% 2705

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Marshall Wace's BHST Position: Q1 2026 in Review

Marshall Wace sold out of BioHarvest Sciences (BHST) in Q1 2026, closing a stake of 21,235 shares — an estimated $110K sold.

Marshall Wace first reported a position in BHST in Q4 2025 and held it in 1 quarter. The position peaked at $110K in Q4 2025. 20 funds tracked by Wall St. Rank hold BHST as of Q1 2026.

  • Marshall Wace reported no remaining BioHarvest Sciences position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 21,235 BioHarvest Sciences shares in Q1 2026, an estimated $110K.
  • Marshall Wace first reported a position in BioHarvest Sciences in Q4 2025 and held it in 1 quarter.
  • Marshall Wace's BioHarvest Sciences position peaked at $110K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.